Canadian non-profit coalition of healthcare professionals and advocates advancing access to psilocybin-assisted psychotherapy. It trains clinicians, supports patients seeking access and advocates for regulatory reform in Canada.
TheraPsil is a Canadian organization founded in 2019 that operates at the intersection of clinical training, patient support, and policy advocacy in psychedelic-assisted therapy. They offer comprehensive training programs in psilocybin and MDMA-assisted therapy for healthcare professionals, ranging from foundational courses to advanced retreats, delivered both in-person and online. The organization also maintains a patient directory connecting qualified individuals to trained providers and offers clear guidance on emerging psychedelic therapeutic modalities.
Beyond education, TheraPsil is actively engaged in grassroots advocacy and legal challenges to advance psychedelic regulations in Canada and internationally. They conduct research initiatives like Project Solace and manage clinical trials, while building community engagement through events, memberships, and volunteer opportunities. The organization's mission reflects the growing evidence base for psychedelics in mental health treatment, positioning them as both an educational hub and a catalyst for institutional change in healthcare policy.
